Arrowhead Pharmaceuticals, Inc...
NasdaqGS:ARWR
$ 24.70
$0.00 (0.00%)
$ 24.70
$0.00 (0.00%)
End-of-day quote: 04/13/2024

ARWR - Arrowhead Pharmaceuticals Stock Prediction 2025 - 2030

20 years of reliable Arrowhead Pharmaceuticals stock forecast. The Wall Street analysts predict Outperform for ARWR. See at a glance whether NasdaqGS:ARWR will rise in the future.

$0.00
Forecast 2023
$28.88
Forecast 2025
$49.08
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$28.88
Forecast 2030
$49.08
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.72
Price-to-book Ratio
16.58
Market Cap
3.66B
TEV
4.30 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$52.00

Arrowhead Pharmaceuticals Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Arrowhead Pharmaceuticals Stock Forecast 2023

$55.00

In the last five quarters, Arrowhead Pharmaceuticals’s Price Target has fallen from $69.85 to $52.00 - a -25.55% decrease. Twelve analysts predict that Arrowhead Pharmaceuticals’s share price will increase in the coming year, reaching $55.00. This would represent an increase of 5.77%.

122.67%
122.67
Last update: 04/14/2024

Highest Price Target $90.00

Average Price Target $55.00

Lowest Price Target $28.00

Arrowhead Pharmaceuticals Stock Forecast 2025

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Jan 2025.

In Jan 2025 analysts predict a share price of $26.94. An increase of 9.08% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Feb 2025.

In Feb 2025 analysts predict a share price of $27.19. An increase of 10.06% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Mar 2025.

In Mar 2025 analysts predict a share price of $27.43. An increase of 11.04% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Apr 2025.

In Apr 2025 analysts predict a share price of $27.67. An increase of 12.02% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in May 2025.

In May 2025 analysts predict a share price of $27.91. An increase of 13% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Jun 2025.

In Jun 2025 analysts predict a share price of $28.15. An increase of 13.98% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Jul 2025.

In Jul 2025 analysts predict a share price of $28.40. An increase of 14.96% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Aug 2025.

In Aug 2025 analysts predict a share price of $28.64. An increase of 15.95% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Sep 2025.

In Sep 2025 analysts predict a share price of $28.88. An increase of 16.93% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Oct 2025.

In Oct 2025 analysts predict a share price of $29.15. An increase of 18.02% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Nov 2025.

In Nov 2025 analysts predict a share price of $29.42. An increase of 19.11% compared to today's share price.

Stock Prediction for the Price of One Arrowhead Pharmaceuticals Share in Dec 2025.

In Dec 2025 analysts predict a share price of $29.69. An increase of 20.2% compared to today's share price.

Arrowhead Pharmaceuticals Stock Predictions 2030

Arrowhead Pharmaceuticals Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $45.79. An increase of 85.39% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $46.20. An increase of 87.05% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $46.61. An increase of 88.72% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $47.03. An increase of 90.39% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $47.44. An increase of 92.05% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $47.85. An increase of 93.72% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $48.26. An increase of 95.39% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $48.67. An increase of 97.05% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $49.08. An increase of 98.72% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $49.54. An increase of 100.57% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $50.00. An increase of 102.42% compared to the previous month's estimate.

Arrowhead Pharmaceuticals Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $50.46. An increase of 104.28% compared to the previous month's estimate.

P/E
0.00
Beta
0.72
Price-to-book Ratio
16.58
Market Cap
3.66B
TEV
4.30 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$52.00

Arrowhead Pharmaceuticals Analyst Ratings Frequently Asked Questions

Who are the analysts watching Arrowhead Pharmaceuticals, Inc.?

The following analysts have recently covered Arrowhead Pharmaceuticals:

B. Riley Securities, Inc.
Chardan Capital Markets, LLC
Citigroup Inc
H.C. Wainwright & Co.
Jefferies LLC
Marktfeld
Piper Sandler Companies
RBC Capital Markets
UBS Investment Bank
Zacks Small-Cap Research
Morgan Stanley
Cantor Fitzgerald & Co.
Citigroup Inc. Research
Leerink Partners LLC
Sanford C. Bernstein & Co., LLC
TD Cowen
BofA Global Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Arrowhead Pharmaceuticals, Inc.?

The following sell-side analysts have recently covered Arrowhead Pharmaceuticals:

Mamtani, Mayank
Nakae, Keay Thomas
Trucchio, Patrick Ralph
Raycroft, Maurice Thomas
Paraskevopoulos, Michail
Tenthoff, Edward Andrew
Issi, Luca
Foroohar, Mani
Merle, Eliana Rachel
Bautz, David
Agrawal, Prakhar
Lebowitz, David Neil
Ulz, Michael Eric
Pickering, William
Smith, Brendan Mychal
Gerberry, Jason Matthew
(This information refers to the last 90 days.)